Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases

This publication has 49 references indexed in Scilit:

• Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
  International Journal of Cancer, 2000
• Elevation of Serum Levels of Metalloproteinase-1, Tissue Inhibitor of Metalloproteinase-1 and Type IV Collagen, and Plasma Levels of Metalloproteinase-9 in Polycystic Kidney Disease
  American Journal of Nephrology, 2000
• Genetic Analysis of MMP3, MMP9, and PAI-1 in Finnish Patients with Abdominal Aortic or Intracranial Aneurysms
  Biochemical and Biophysical Research Communications, 1999
• Epidermal Expression of Collagenase Delays Wound-Healing in Transgenic Mice
  Journal of Investigative Dermatology, 1998
• The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study
  Atherosclerosis, 1998
• A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
  Nature Genetics, 1998
• Cross-talk between Different Enhancer Elements during Mitogenic Induction of the Human Stromelysin-1 Gene
  Journal of Biological Chemistry, 1996
• Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
  Heart, 1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
  Cell, 1987